Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2019-2029
Global Vaccine Contract Manufacturing Market Report 2019-2029
Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing
The global vaccine contract manufacturing market was worth $1.9bn in 2018 and is expected to grow at a CAGR of 9.3% from 2019-2023. In 2018, the paediatric vaccines segment held 48% of the global vaccine contract manufacturing market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 217-page report you will receive 80 tables and 57 figures– all unavailable elsewhere.
The 217-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Revenue and growth forecasts from 2019 to 2029 for the global vaccine market
• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market
• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by type:
• Paediatric Vaccines
• Adult Vaccines
• Influenza Vaccines
• Therapeutic Vaccines
• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing
• Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan and India
• Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa
The regional markets are further broken down by type and workflow.
• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• Evonik Degusa
• IDT Biologika
• Lonza
• Meridian Life Science
• Nipro Corporation
• Pfizer CentreOne
• Sigma Aldrich Fine Chemicals
• SynCo Bio Partners
• Vetter Pharmaceutical
• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.
• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.
• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2018?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2019 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
• How will the industry evolve during the period between 2019 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.
Buy our report today Global Vaccine Contract Manufacturing Market Analysis : Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 World Vaccine Contract Manufacturing Market Highlights
1.2 Why You Should Read This Report?
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Associated Visiongain Reports
1.8 Frequently Asked Questions (FAQ)
2. Introduction to Vaccines
2.1 The History of Vaccines
2.2 How Do Vaccines Work?
2.2.1 Artificial Immunity
2.3 Types of Vaccine
2.3.1 Live, Attenuated Vaccines (LAVs)
2.3.2 Recombinant Live Vaccines
2.3.3 Inactivated Vaccines
2.3.4 Toxoid Vaccines
2.3.5 Subunit Vaccines
2.3.6 Conjugate Vaccines
2.3.7 Recombinant Subunit Vaccines
2.3.8 DNA Vaccines
2.3.9 Recombinant Vector Vaccines
2.3.10 Therapeutic Vaccines
2.4 Diseases Preventable with Vaccines
2.5 The Rise of the Vaccines Market
2.6 Technological and Regulatory Improvements
3. Vaccine Manufacturing Technologies, 2018
3.1 Summary of Vaccine Technology Trends
3.2 New Substrates for Vaccine Production
3.2.1 Shift towards Cell-Based Manufacturing Technology
3.2.2 Benefits of Cell-Based Techniques
3.2.3 Mammalian Cell Lines
3.2.3.1 Madin Darby Canine Kidney Cells (MDCK)
3.2.3.2 Vero Cells
3.2.3.3 PerC6 Cells
3.2.4 Avian-Derived Cell Lines
3.2.4.1 EB66 Stem Cell Technology: Vivalis
3.2.5 Plant-Based Vaccines
3.2.5.1 Medicago’s Proficia VLP Vaccine Technology
3.2.6 Insect Egg-Based Production Systems
3.2.6.1 Novavax
3.2.6.2 Protein Sciences Corporation (PSC)
3.3 Next-Generation Expression Systems and Vectors: Increasing Production Yield
3.3.1 AdVac Technology: Crucell
3.3.2 AdCEV Vectors: AfriVax
3.3.3 Pfenex Expression Technology: Pfenex
3.4 Equipment Trends
3.4.1 The Shift Towards Disposable Single-use Equipment
3.4.2 Bioreactors and Vaccine Production
3.4.2.1 Single-Use Bioreactors
3.4.2.2 Main Applications of Disposable Bioreactors
3.4.2.3 Current Single-Use Bioreactor Systems in the Market
3.5 Prefilled Syringes and Vaccines
3.5.1 Growing Market for Pre-Filled Syringes
3.5.2 Pre-Filled Vaccine Products
3.5.3 Drivers and Restraints for Pre-Filled Syringes
3.5.4 Product Stability and Quality Assurance Programme
3.5.4.1 Paediatric H1N1 Vaccine
3.5.4.2 Reported Challenges Flu Vaccines
3.5.4.3 Novartis' Agriflu and Fluad Ban is Lifted
3.5.4.4 Baxter Flu Vaccine and Side Effects
3.5.4.5 Reported Shelf Life with H1N1 Vaccine
3.6 Lyophilisation and Vaccine Manufacturing
3.6.1 Lyophilisation of Vaccines Will Increase
3.7 Cell Media Can Improve Virus Yield
4. The Global Vaccine Manufacturing Market 2019-2029
4.1 Overview of the Global Vaccine Manufacturing Market 2019-2029
4.2 World Vaccine Market Forecast 2019-2029
4.3 The Global Vaccine Market by Submarket, 2018 and 2019
4.4 Growth in Vaccine Market Will Drive Efficiency in Vaccine Manufacturing
4.5 Paediatric Vaccines Market Overview
4.6 Adult Prophylactic Vaccines Market Overview
4.7 Influenza Vaccines Market Overview
4.8 Therapeutic Vaccines Market Overview
5. The Global Vaccine Contract Manufacturing 2019-2029
5.1 Outsourcing in the Pharmaceutical and Biotechnology Industry
5.1.1 Reasons to Outsource
5.1.2 Benefits of Outsourcing
5.1.3 The Challenges in Outsourcing Vaccine Manufacturing
5.1.4 Why Should Companies Outsource Vaccine Manufacturing?
5.1.5 Strategic Outsourcing Vs Tactical Outsourcing
5.1.6 Virtual Companies
5.2 Contract Manufacturing Organisations (CMOs)
5.2.1 Manufacturing Services Offered by CMOs
5.2.2 Vaccine Manufacturing Activities Typically Outsourced
5.3 The Vaccine Contract Manufacturing Market: Overall Revenue Forecast 2019-2029
5.4 Contract Manufacturing Market for Vaccines 2018-2029
5.4.1 Market Size for Contract Manufacturing of Vaccines 2018
5.4.2 Vaccine Contract Manufacturing Market Forecast 2019-2029
6. Vaccine Contract Manufacturing Market by Vaccine Type, 2019-2029
6.1 Paediatric Vaccines
6.2 Adult Vaccines
6.3 Influenza Vaccines
6.4 Therapeutic Vaccines
7. Vaccine Contract Manufacturing Market by Workflow, 2019-2029
7.1 Downstream Processing
7.1.1 Fill & Finish Operations
7.1.2 Analytical & QC Studies
7.1.3 Packaging
7.2 Upstream Processing
7.2.1 Mammalian Expression Systems
7.2.2 Bacterial Expression Systems
7.2.3 Yeast Expression Systems
7.2.4 Baculovirus/Insect Expression Systems
7.2.5 Other Upstream Processing
8. Leading National Markets for Vaccine Contract Manufacturing, 2019-2029
8.1 Leading National Markets for Vaccine Contract Manufacturing
8.2 North America Vaccine Contract Manufacturing Market, 2018-2029
8.2.1 US Vaccine Contract Manufacturing Market Forecast, 2018-2029
8.2.2 Canada Vaccine Contract Manufacturing Market Forecast, 2018-2029
8.3 The Europe Vaccine Contract Manufacturing Market, 2018-2029
8.3.1 Germany Vaccine Contract Manufacturing Market, 2016-2028
8.3.2 UK Vaccine Contract Manufacturing Market, 2018-2029
8.3.3 French Vaccine Contract Manufacturing Market, 2018-2029
8.3.4 Italy Vaccine Contract Manufacturing Market, 2018-2029
8.3.5 Spain Vaccine Contract Manufacturing Market, 2018-2029
8.4 Asia-Pacific Vaccine Contract Manufacturing Market, 2018-2029
8.4.1 Japan Vaccine Contract Manufacturing Market, 2018-2029
8.4.2 China Vaccine Contract Manufacturing Market, 2018-2029
8.4.3 India Vaccine Contract Manufacturing Market, 2018-2029
8.5 Rest of the World Vaccine Contract Manufacturing Market, 2018-2029
8.5.1 Brazil Vaccine Contract Manufacturing Market, 2018-2029
8.5.2 Mexico Vaccine Contract Manufacturing Market, 2018-2029
8.5.3 Russia Vaccine Contract Manufacturing Market, 2018-2029
8.5.4 South Africa Vaccine Contract Manufacturing Market, 2019-2029
9. Leading Vaccine Contract Manufacturing Companies, 2018-2029
9.1 Leading Vaccine Contract Manufacturing Organisations
9.2 Baxter BioPharma Solutions
9.2.1 Recent Financial Performance
9.2.2 Key Developments
9.3 Boehringer Ingelheim
9.3.1 Recent Financial Performance
9.3.2 Ben Venue Laboratories
9.3.3 Manufacturing Deals 2011-2017
9.4 Catalent
9.4.1 Recent Financial Performance
9.4.2 Catalent: Financial Performance by Segment, 2011-2016
9.4.3 Catalent Injectable Vaccines
9.4.4 Catalent: Zydis Technology
9.4.5 Regional Market Expansion Strategy
9.5 Charles River Laboratories
9.5.1 Recent Financial Performance, 2011-2017
9.5.2 Financial Performance by Segment, 2012-2018
9.5.3 Vaccine Manufacturing Services
9.5.4 Charles River Avian Vaccine Services
9.5.5 Vaccine Manufacturing Expansion
9.5.6 Outlook and Early Stage Restructuring
9.5.7 Partnerships
9.5.7.1 Partnership with AstraZeneca
9.5.7.2 Partnership with Batavia
9.6 IDT Biologika GmbH
9.7 Lonza
9.7.1 Recent Financial Performance
9.7.2 Manufacturing Division Restructuring
9.8 Meridian Life Science
9.8.1 Recent Financial Performance, 2012-2018
9.9 Sigma-Aldrich Fine Chemicals (SAFC) (Merck KGaA)
9.10 SynCo Bio Partners
9.10.1 Recent Developments
9.10.1.1 Expansion of Facilities
9.10.1.2 FDA Approval of Partner Application
9.11 AbbVie Contract Manufacturing
9.11.1 AbbVie Offers Full-Service Contract Manufacturing
9.11.2 Recent Financial Performance: Revenue 2012-2017
9.11.3 Strategic Developments 2017-2018
9.12 Evonik Degussa
9.12.1 API and Drug Delivery Services
9.13 Vetter Pharmaceutical
9.13.1 Financial Performance, 2013-2017
9.13.2 Regional Expansion
9.14 Pfizer CentreOne
9.14.1 Financial Performance, 2013-2018
9.14.2 Strategic Developments 2017-2018
9.15 Nipro Corporation
9.15.1 Contract Manufacturing Capabilities
10. Global Vaccine Contract Manufacturing Market: World Market Trends 2018-2029
10.1 Vaccine Contract Manufacturing Industry Trends
10.2 Strengths
10.2.1 Many Companies Cannot Afford In-house Capabilities
10.2.2 Outsourcing Improves Time to Market
10.2.3 Manufacturers Get Access to Specialised Technologies
10.2.4 Shift Towards Emerging Markets as Favourable Outsourcing Destinations
10.3 Weaknesses
10.3.1 Mass Vaccine Manufacturing Kept In-house
10.3.2 A Highly-Fragmented Vaccine Contract Manufacturing Market
10.3.3 An Unpredictable Supply and Demand Business Model
10.4 Opportunities
10.4.1 Many Vaccines in the Product Pipeline
10.4.2 Emerging Market’s Growing Demand for Vaccines
10.4.2.1 Dynamic Change: Emerging Markets are Major Vaccine Developers
10.4.3 Changing World Demographics
10.5 Threats
10.5.1 Post Recession: Biotech Suffer from Severe Cuts in Capital Funding
10.5.2 The Public are Slow to Accept Novel Technologies
10.5.3 Perception of Risk by the Original Vaccine Manufacturers
11. Conclusion
11.1 Overview
11.2 Regulatory and Quality Standards Create High Barriers of Entry
11.3 Emerging Markets Will Show Stronger Growth
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 2.1 Timeline of Key Events in Vaccine Development, c.1000 AD – Present
Table 3.1 Vaccine Development Pipeline Using Crucell’s AdVac Technology
Table 3.2 Benefits and Drawbacks of Using Disposable Technology for Vaccine Production
Table 3.3 Companies Providing Disposable Biomanufacturing Platforms/Systems
Table 3.4 Some Leading Pre-Filled Syringe Vaccine Products
Table 3.5 Prominent Lyophilised Vaccines
Table 3.6 Examples of Serum-Free Media for Vaccine Manufacturing
Table 4.1 The Global Vaccine Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) 2018-2029
Table 4.2 The Global Vaccine Market: Revenue ($bn) and Market Share by Submarket (%), 2018-2019
Table 5.1 The Global Vaccine Contract Manufacturing Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.1 Global Paediatric Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.2 Global Adult Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.3 Global Influenza Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.4 Global Therapeutic Vaccines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.1 Global Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.2 Global Fill & Finish Operations Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.3 Global Analytical & QC Studies Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.4 Global Packaging Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.5 Global Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.6 Global Mammalian Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.7 Global Bacterial Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.8 Global Yeast Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.9 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.10 Global Other Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.1 Leading National Vaccine Contract Manufacturing Markets Forecast: Revenue ($m) and Market Share (%), 2018-2019
Table 8.2 North America Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.3 North America Vaccine Contract Manufacturing Market, By Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.4 North America Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.5 North America Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.6 North America Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.7 US Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.8 Canada Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.9 Europe Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.10 Europe Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.11 Europe Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.12 Europe Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.13 Europe Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.14 Germany Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.15 UK Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.16 France Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.17 Italy Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.18 Spain Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.19 Asia-Pacific Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.20 Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.21 Asia-Pacific Vaccine Contract Manufacturing Marke by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.22 Asia Pacific Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.23 Asia Pacific Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.24 Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.25 Chinese Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.26 Indian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.27 RoW Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.28 RoW Vaccine Contract Manufacturing Market by Vaccine Type Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.29 RoW Vaccine Contract Manufacturing Market by Workflow Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.30 RoW Downstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.31 RoW Upstream Processing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.32 Brazilian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.33 Mexican Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.34 Russian Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 8.35 South Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 9.1 Baxter BioPharma Solutions Overview
Table 9.2 Baxter BioPharma Manufacturing: Revenue ($m), Annual Growth (%), CAGR (%), 2013-2018
Table 9.3 Boehringer Ingelheim Biopharmaceuticals Overview
Table 9.4 Boehringer Ingelheim: Biopharmaceuticals Revenue ($m) and Annual Growth Rate (%), 2012-2018
Table 9.5 Catalent Overview
Table 9.6 Catalent: Revenue($m) and AGR (%), 2012-2018
Table 9.7 Charles River Laboratories: Revenue ($m) and AGR (%), 2012-2018
Table 9.8 Charles River Laboratories: Newly Revised Reportable Segments
Table 9.9 Charles River Laboratories: cGMP Vaccine Manufacturing and Testing Capabilities
Table 9.10 Lonza Custom Manufacturing: Revenue ($m) and AGR (%), 2010-2016
Table 9.11 Meridian Bioscience: Revenue ($m), AGR (%), 2012-2018
Table 9.12 SynCo Bio Partners Capabilities
Table 9.13 AbbVie Contract Manufacturing: Details, 2017
Table 9.14 Evonik Degussa Details, 2018
Table 9.15 Vetter Details, 2017
Table 9.16 Vetter Pharmaceutical Manufacturing: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2017
Table 9.17 Pfizer CentreOne Details, 2018
Table 9.18 Pfizer CentreSource: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2018
Table 9.19 Nipro Pharma Overview
Table 9.20 Nipro Pharmaceutical Contract Manufacturing Capabilities: 2011-2017
Table 10.1 SWOT Analysis of the Vaccine Contract Manufacturing Market
List of Figures
Figure 3.1 Influenza Vaccine Production Using a Cell-Based Manufacturing Method
Figure 3.2 Medicago’s Product Pipeline
Figure 3.3 Novavax’ Insect Egg-Based Vaccine Production Process
Figure 3.4 Pre-filled Syringes Market: Drivers and Restraints, 2019-2029
Figure 4.1 The Global Vaccine Market Forecast: Revenue ($bn), AGR (%) 2018-2029
Figure 4.2 The Global Vaccine Market: Market Share by Submarket (%), 2018
Figure 5.1 Selected Tasks Outsourced in the Pharmaceutical and Biotech Industry
Figure 5.2 Global Vaccine Contract Manufacturing Forecast: Revenue ($m), 2019, 2023 and 2029
Figure 5.3 The Global Vaccine Contract Manufacturing Forecast: Revenue ($Mn) and AGR (%), 2018-2029
Figure 6.1 Global Vaccine Contract Manufacturing Forecast by Vaccine Type: Revenue ($m), 2018-2029
Figure 6.2 Global Vaccine Contract Manufacturing Forecast by Vaccine Type: Market Share (%), 2018-2029
Figure 6.3 Global Paediatric Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 6.4 Global Adult Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 6.5 Global Influenza Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 6.6 Global Therapeutic Vaccines Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.1 Global Vaccine Contract Manufacturing Forecast by Workflow: Revenue ($m), 2018-2029
Figure 7.2 Global Vaccine Contract Manufacturing Forecast, By Workflow: Market Share (%), 2018-2029
Figure 7.3 Global Downstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.4 Global Fill & Finish Operations Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.5 Global Analytical & QC Studies Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.6 Global Packaging Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.7 Global Upstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.8 Global Mammalian Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.9 Global Bacterial Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.10 Global Yeast Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.11 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 7.12 Global Other Upstream Processing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.1The Leading National Vaccine Contract Manufacturing: Market Share (%) by Region, 2018
Figure 8.2 North America Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.3 U.S. Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.4 Canada Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.5 Europe Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.6 Germany Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.7 UK Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.8 France Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.9 Italy Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.10 Spain Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.11 Asia-Pacific Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.12 Japanese Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.13 Chinese Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.14 Indian Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.15 RoW Vaccine Contract Manufacturing: Market Share (%) by Region, 2018-2029
Figure 8.16 Brazilian Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.17 Mexican Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.18 Russia Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 8.19 South Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($m) and AGR (%), 2018-2029
Figure 9.1 Baxter BioPharma Manufacturing: Revenue ($m), 2013-2018
Figure 9.2 Boehringer Ingelheim: Biopharmaceuticals Revenue ($m) and Annual Growth Rate (%), 2012-2018
Figure 9.3 Catalent: Revenue ($m) and AGR (%), 2012-2018
Figure 9.4 Catalent Financial Performance by Division: Revenue ($m), 2013-2018
Figure 9.5 Charles River Laboratories: Revenue ($m) and AGR (%), 2012-2018
Figure 9.6 Lonza Custom Manufacturing: Revenue ($m) and AGR (%), 2010-2016
Figure 9.7 Meridian Bioscience: Revenue ($m), and AGR (%), 2012-2018
Figure 9.8 Nipro Pharmaceutical Contract Manufacturing Capabilities: Orally Administered Drugs, Injectables, External Preparations, 2011-2017
Figure 10.1 Drivers and Restraints for the Vaccine Contract Manufacturing Sector
Figure 11.1 The Global Vaccine Contract Manufacturing Market: Market Share by Region (%), 2018, 2023, 2029
Figure 11.2 The Global Vaccine Contract Manufacturing: National Market Share (%), 2018 – 2029
AbbVie
Accugenix
AfriVax
Alkion Biopharma SAS
AmProtein
Antigenics, Inc.
Arabio
Argenta
Artelis
Astrazeneca
ATM Life Sciences
ATMI
Bacteriological Institute of the Anhaltian Administrative Areas
Batavia Bioservices
Baxter BioPharma
Berna Biotech
Bharat Biotech International Limited
Binnopharm
BioFocus
Biovest
Boehringer Ingelheim
Bristol-Myers Squibb Company
Cadila Pharmaceuticals
Calico
Catalent
Cellexus Limited
Charles River Laboratories
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Colorcon
Crucell
CSL Biotherapies
Daiichi Sankyo Co. Ltd.
Elanco
Eli Lilly
Evonik Degussa
FiberCell
Gallant Custom Laboratories
GE Healthcare
GE Wave Biotech
GlaxoSmithKline Biologics
GSAL
GlaxoSmithKline (GSK)
Hikma
Hyclone
IDT Biologika GmbH
Intercell Corporation
Invitrogen
Irvine Scientific
Janssen Biotech, Inc. (Janssen)
Klocke Group
Kuhner
LG Life Sciences
Lonza
Medicago
Meissner Filtration
Merck & Company
Merck Millipore
Meridian Bioscience
Meridian Life Science
MGC Pharma Co.
Millipore
Mitsubishi Tanabe Pharma
MorphoSys
Mosquirix
MP Biomedicals
Mylan
Neurocrine Biosciences
Nipro Corporation
Novartis
Novartis Vaccines and Diagnostics
Novavax
Organon Teknika Corporation
Pall Life Sciences
PATH
Patheon
Pfizer
Pharmaceutical Base Development Co., Ltd.
Pharmacyclics LLC
Philip Morris International
Pierre-Guerin Biolafitte
Protein Sciences Corporation
Refine Technology
Samsung Bioepis
Sanofi
Sanofi Pasteur
Sartorius Stedim Biotech
Scripps Research
Shanghai Zhangjiang Biotech
ShangPharma Corporation
Sigma Aldrich
Sigma-Aldrich Fine Chemicals
SynCo Bio Partners
SynCo Bio Partners (SynCo)
Thermo Fisher
Vetter Pharmaceutical
Vivalis
Voyager Therapeutics, Inc.
Wave Biotech (GE Healthcare Life Sciences)
Wynca
Xcellerex (GE Healthcare Life Sciences)
ZellWerk
Zhejiang Jiang Yuan Tang Biotechnology Corporation
List of Organizations Mentioned in the Report
Centers for Disease Control and Prevention (CDC)
Defense Advanced Research Projects Agency (DARPA)
European Medicine Agency (EMA)
Food and Drug Administration (FDA)
Institute Pasteur in Paris
Japanese Ministry of Health, Labour and Welfare (MHLW)
National Institute of Allergy and Infectious Diseases (NIAID)
Download sample pages
Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029
Related reports
-
Lyophilization in Pharmaceutical Market Forecast 2019-2029
The global lyophilization in pharmaceutical market is estimated to have reached $5.6bn in 2018. The pharmaceutical and biotechnology segment held...Full DetailsPublished: 28 March 2019 -
Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018
Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the...Full DetailsPublished: 28 September 2018 -
Drug Delivery Technologies Market Forecast 2019-2029
The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the...
Full DetailsPublished: 27 February 2019 -
Pharma Clinical Trial Services Market and Industry Forecast 2017-2027
The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of...
Full DetailsPublished: 11 July 2017 -
Top 50 Bioreactor Manufacturers 2019
Asia-Pacific bioreactors market is anticipated to be the fast-growing market in the forecast period with a CAGR of 8.0% from...
Full DetailsPublished: 25 March 2019 -
Indian Pharmaceutical Market Forecast 2019-2029
The Indian pharmaceuticals market is estimated to have reach $28.8bn in 2018 and is expected to grow at a CAGR...
Full DetailsPublished: 09 May 2019 -
Global Biosimilars and Follow-On Biologics Market 2019-2029
The global biosimilars and follow-on biologics market is estimated to have reached $10.7bn in 2018 and expected to grow at...
Full DetailsPublished: 21 March 2019 -
Top 20 Vaccines Manufacturers 2019
The global vaccines market has witnessed strong growth in past few years. The top 5 manufacturers in the global vaccines...
Full DetailsPublished: 12 February 2019 -
Global Clinical Trial Management System Market Forecast 2020-2030
The global market for clinical trial management systems was valued to be $1,152m in 2019 and is valued to reach...
Full DetailsPublished: 17 March 2020 -
Global Influenza Vaccines Market Outlook 2019-2029
The latest report from business intelligence provider visiongain offers comprehensive analysis of the global influenza vaccines market. Visiongain assesses that...
Full DetailsPublished: 05 July 2019
Download sample pages
Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029
Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024